508 related articles for article (PubMed ID: 18381449)
1. Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity.
Agostinho M; Santos V; Ferreira F; Costa R; Cardoso J; Pinheiro I; Rino J; Jaffray E; Hay RT; Ferreira J
Cancer Res; 2008 Apr; 68(7):2409-18. PubMed ID: 18381449
[TBL] [Abstract][Full Text] [Related]
2. Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform.
Wessel I; Jensen LH; Jensen PB; Falck J; Rose A; Roerth M; Nitiss JL; Sehested M
Cancer Res; 1999 Jul; 59(14):3442-50. PubMed ID: 10416608
[TBL] [Abstract][Full Text] [Related]
3. Topoisomerase II inhibitors affect entry into mitosis and chromosome condensation in BHK cells.
Anderson H; Roberge M
Cell Growth Differ; 1996 Jan; 7(1):83-90. PubMed ID: 8788036
[TBL] [Abstract][Full Text] [Related]
4. SUMO-2/3 regulates topoisomerase II in mitosis.
Azuma Y; Arnaoutov A; Dasso M
J Cell Biol; 2003 Nov; 163(3):477-87. PubMed ID: 14597774
[TBL] [Abstract][Full Text] [Related]
5. PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes.
Azuma Y; Arnaoutov A; Anan T; Dasso M
EMBO J; 2005 Jun; 24(12):2172-82. PubMed ID: 15933717
[TBL] [Abstract][Full Text] [Related]
6. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
Morgan SE; Cadena RS; Raimondi SC; Beck WT
Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
[TBL] [Abstract][Full Text] [Related]
7. RanBP2: a tumor suppressor with a new twist on TopoII, SUMO, and centromeres.
Navarro MS; Bachant J
Cancer Cell; 2008 Apr; 13(4):293-5. PubMed ID: 18394551
[TBL] [Abstract][Full Text] [Related]
8. The SUMO-targeted ubiquitin ligase RNF4 localizes to etoposide-exposed mitotic chromosomes: implication for a novel DNA damage response during mitosis.
Saito M; Fujimitsu Y; Sasano T; Yoshikai Y; Ban-Ishihara R; Nariai Y; Urano T; Saitoh H
Biochem Biophys Res Commun; 2014 Apr; 447(1):83-8. PubMed ID: 24695317
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle progression and chromosome segregation in mammalian cells cultured in the presence of the topoisomerase II inhibitors ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane; ADR-529] and ICRF-159 (Razoxane).
Gorbsky GJ
Cancer Res; 1994 Feb; 54(4):1042-8. PubMed ID: 8313360
[TBL] [Abstract][Full Text] [Related]
10. Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activity.
Mo YY; Beck WT
Exp Cell Res; 1999 Oct; 252(1):50-62. PubMed ID: 10502399
[TBL] [Abstract][Full Text] [Related]
11. Both alpha and beta isoforms of mammalian DNA topoisomerase II associate with chromosomes in mitosis.
Null AP; Hudson J; Gorbsky GJ
Cell Growth Differ; 2002 Jul; 13(7):325-33. PubMed ID: 12133901
[TBL] [Abstract][Full Text] [Related]
12. Mitotic kinase Aurora-B is regulated by SUMO-2/3 conjugation/deconjugation during mitosis.
Ban R; Nishida T; Urano T
Genes Cells; 2011 Jun; 16(6):652-69. PubMed ID: 21554500
[TBL] [Abstract][Full Text] [Related]
13. Top2 SUMO conjugation in yeast cell lysates.
Baldwin M; Bachant J
Methods Mol Biol; 2009; 582():209-19. PubMed ID: 19763952
[TBL] [Abstract][Full Text] [Related]
14. Sodium salicylate is a novel catalytic inhibitor of human DNA topoisomerase II alpha.
Bau JT; Kurz EU
Biochem Pharmacol; 2011 Feb; 81(3):345-54. PubMed ID: 20959117
[TBL] [Abstract][Full Text] [Related]
15. A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells/.
Downes CS; Clarke DJ; Mullinger AM; Giménez-Abián JF; Creighton AM; Johnson RT
Nature; 1994 Dec; 372(6505):467-70. PubMed ID: 7984241
[TBL] [Abstract][Full Text] [Related]
16. The SUMO pathway is required for selective degradation of DNA topoisomerase IIbeta induced by a catalytic inhibitor ICRF-193(1).
Isik S; Sano K; Tsutsui K; Seki M; Enomoto T; Saitoh H; Tsutsui K
FEBS Lett; 2003 Jul; 546(2-3):374-8. PubMed ID: 12832072
[TBL] [Abstract][Full Text] [Related]
17. Mitotic arrest induced by a novel family of DNA topoisomerase II inhibitors.
León LG; Ríos-Luci C; Tejedor D; Pérez-Roth E; Montero JC; Pandiella A; García-Tellado F; Padrón JM
J Med Chem; 2010 May; 53(9):3835-9. PubMed ID: 20405921
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors.
Ishida R; Miki T; Narita T; Yui R; Sato M; Utsumi KR; Tanabe K; Andoh T
Cancer Res; 1991 Sep; 51(18):4909-16. PubMed ID: 1654205
[TBL] [Abstract][Full Text] [Related]
19. SUMOylation regulates polo-like kinase 1-interacting checkpoint helicase (PICH) during mitosis.
Sridharan V; Park H; Ryu H; Azuma Y
J Biol Chem; 2015 Feb; 290(6):3269-76. PubMed ID: 25564610
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta.
Marchion DC; Bicaku E; Turner JG; Daud AI; Sullivan DM; Munster PN
Clin Cancer Res; 2005 Dec; 11(23):8467-75. PubMed ID: 16322310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
